HGF and non-small cell lung carcinoma: In all ficlatuzumab-treated patients, serum HGF levels were increased compared with baseline, likely due to the stabilization of HGF upon complex formation with ficlatuzumab.52 A phase Ib trial evaluated combination treatment with ficlatuzumab and gefitinib in 15 molecularly unselected Asian NSCLC patients.